Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Human biochemistry of the isoprostane pathway.

Milne GL, Yin H, Morrow JD.

J Biol Chem. 2008 Jun 6;283(23):15533-7. doi: 10.1074/jbc.R700047200. Epub 2008 Feb 19. Review. No abstract available.

2.

Lipid peroxidation and neurodegenerative disease.

Reed TT.

Free Radic Biol Med. 2011 Oct 1;51(7):1302-19. doi: 10.1016/j.freeradbiomed.2011.06.027. Epub 2011 Jun 30. Review.

PMID:
21782935
3.

The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation.

Roberts LJ 2nd, Fessel JP, Davies SS.

Brain Pathol. 2005 Apr;15(2):143-8. Review.

PMID:
15912887
4.

Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA.

Br J Pharmacol. 2014 Jul;171(13):3115-31. doi: 10.1111/bph.12677. Review.

5.

Lipid peroxidation, isoprostanes and vascular damage.

Minuz P, Fava C, Lechi A.

Pharmacol Rep. 2006;58 Suppl:57-68. Review.

6.

Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.

Musiek ES, Yin H, Milne GL, Morrow JD.

Lipids. 2005 Oct;40(10):987-94. Review.

PMID:
16382569
7.

Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.

Greco A, Minghetti L.

Curr Neurovasc Res. 2004 Oct;1(4):341-54. Review.

PMID:
16181083
8.

The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.

Roberts LJ 2nd, Fessel JP.

Chem Phys Lipids. 2004 Mar;128(1-2):173-86. Review.

PMID:
15037162
9.

Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?

Roy J, Le Guennec JY, Galano JM, Thireau J, Bultel-Poncé V, Demion M, Oger C, Lee JC, Durand T.

Biochimie. 2016 Jan;120:56-61. doi: 10.1016/j.biochi.2015.06.010. Epub 2015 Jun 23. Review.

PMID:
26112019
10.

Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.

Miller E, Morel A, Saso L, Saluk J.

Oxid Med Cell Longev. 2014;2014:572491. doi: 10.1155/2014/572491. Epub 2014 Apr 29. Review.

11.

[The present-day look at lipid peroxidation].

Luczaj W, Skrzydlewska E.

Postepy Biochem. 2006;52(2):173-9. Review. Polish.

PMID:
17078507
12.

Free radicals and aging.

Barja G.

Trends Neurosci. 2004 Oct;27(10):595-600. Review.

PMID:
15374670
13.

Novel eicosanoids. Isoprostanes and related compounds.

Roberts LJ 2nd, Brame CJ, Chen Y, Morrow JD.

Methods Mol Biol. 1999;120:257-85. Review.

PMID:
10343322
14.

[Isoprostanes and oxidative stress in brain damage in newborns].

Minghetti L, Bernardo A, Greco A.

Ann Ist Super Sanita. 2001;37(4):537-43. Review. Italian.

PMID:
12046223
16.

Hyperlipidaemia and cardiovascular disease: oxidative damage and atherosclerosis.

Le NA.

Curr Opin Lipidol. 2006 Feb;17(1):92-4. Review. No abstract available.

PMID:
16407721
17.

The pulmonary biology of isoprostanes.

Janssen LJ, Catalli A, Helli P.

Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):244-55. Review.

PMID:
15650412
18.

Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE...

Long EK, Picklo MJ Sr.

Free Radic Biol Med. 2010 Jul 1;49(1):1-8. doi: 10.1016/j.freeradbiomed.2010.03.015. Epub 2010 Mar 29. Review.

PMID:
20353821
19.

Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.

Roberts LJ 2nd, Morrow JD.

Cell Mol Life Sci. 2002 May;59(5):808-20. Review.

PMID:
12088281
20.

The isoprostanes: unique products of arachidonic acid oxidation-a review.

Fam SS, Morrow JD.

Curr Med Chem. 2003 Sep;10(17):1723-40. Review.

PMID:
12871112

Supplemental Content

Support Center